Skip Navigation


ToxSci Advance Access originally published online on January 19, 2006
Toxicological Sciences 2006 90(2):586-595; doi:10.1093/toxsci/kfj111
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
90/2/586    most recent
kfj111v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kim, N. D.
Right arrow Articles by Copple, B. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, N. D.
Right arrow Articles by Copple, B. L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Early Growth Response Factor-1 Is Critical for Cholestatic Liver Injury

Nam Deuk Kim*,{dagger}, Jeon-OK Moon*,{dagger}, Angela L. Slitt* and Bryan L. Copple*,1

* Department of Pharmacology, Toxicology, and Experimental Therapeutics, University of Kansas Medical Center, Kansas City, Kansas 66160; and {dagger} Department of Pharmacy, Pusan National University, Pusan 609–735, South Korea

Received September 6, 2005; accepted January 14, 2006

Hepatocyte injury during cholestasis depends in part on the release of proinflammatory mediators that cause neutrophils to accumulate in the liver and become activated to damage hepatocytes. The mechanism by which cholestasis stimulates production of proinflammatory mediators in the liver is not completely understood. The studies presented here tested the hypothesis that the transcription factor early growth response factor-1 (Egr-1) is required for inflammation to occur in the liver during cholestasis. The results of these studies show that Egr-1 was rapidly upregulated, primarily in hepatocytes, in mice subjected to bile duct ligation, an animal model of cholestasis. To determine whether Egr-1 was required for inflammation and hepatocyte injury during cholestasis, bile duct ligation was performed in wild-type and Egr-1 knockout mice. Hepatocyte injury, neutrophil accumulation, and upregulation of macrophage inflammatory protein-2 (MIP-2) and intercellular adhesion molecule-1 (ICAM-1) in the liver were significantly reduced in Egr-1 knockouts. By contrast, levels of tumor necrosis factor-alpha (TNF-{alpha}) and collagen (i.e., a biomarker of liver fibrosis) were not different between wild-types and Egr-1 knockouts subjected to bile duct ligation. Because hepatocytes are exposed to elevated concentrations of bile acids during cholestasis, it was determined that bile acids upregulate Egr-1 in primary mouse hepatocytes. Deoxycholic acid dose-dependently increased Egr-1 protein in hepatocytes. Results from these studies suggest a scenario in which elevated concentrations of bile acids during cholestasis increase expression of Egr-1 in hepatocytes. Egr-1 then upregulates proinflammatory mediators that cause neutrophils to accumulate in the liver and become activated to damage hepatocytes.

Key Words: cholestasis; early growth response factor-1; liver; inflammation; bile acids.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J.-O. Moon, T. P. Welch, F. J. Gonzalez, and B. L. Copple
Reduced liver fibrosis in hypoxia-inducible factor-1{alpha}-deficient mice
Am J Physiol Gastrointest Liver Physiol, March 1, 2009; 296(3): G582 - G592.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. Kong, J. P. Luyendyk, O. Tawfik, and G. L. Guo
Farnesoid X Receptor Deficiency Induces Nonalcoholic Steatohepatitis in Low-Density Lipoprotein Receptor-Knockout Mice Fed a High-Fat Diet
J. Pharmacol. Exp. Ther., January 1, 2009; 328(1): 116 - 122.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Larade, Z. Jiang, Y. Zhang, W. Wang, S. Bonner-Weir, H. Zhu, and H. F. Bunn
Loss of Ncb5or Results in Impaired Fatty Acid Desaturation, Lipoatrophy, and Diabetes
J. Biol. Chem., October 24, 2008; 283(43): 29285 - 29291.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
S.-B. Kwon, J.-S. Park, J.-Y. Yi, J.-W. Hwang, M. Kim, M.-O. Lee, B.-H. Lee, H.-L. Kim, J. H. Kim, H. Chung, et al.
Time- and Dose-based Gene Expression Profiles Produced by a Bile-duct-damaging Chemical, 4,4'-methylene Dianiline, in Mouse Liver in an Acute Phase
Toxicol Pathol, July 1, 2008; 36(5): 660 - 673.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.